NPS Pharmaceuticals, Inc. (NPSP) Joins the Oley Foundation in Recognizing HPN Awareness Week, August 5-11  
8/6/2012 9:54:33 AM

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced its support for the Oley Foundation’s second annual HPN Awareness Week, which is held August 5-11, 2012. HPN, or Home Parenteral Nutrition, is an intravenous fluid for patients who are unable to obtain enough nutrients to survive through a normal diet, most often due to digestive disorders such as short bowel syndrome. The goal of the observance is to bring attention to the HPN community and help its members realize that they can lead enriched and fulfilling lives, despite the challenges they face.